Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,314 | 50,436 | 14,289 | 14,755 | 27,380 |
| Receivables | 768 | N/A | N/A | N/A | N/A |
| Inventories | 2,309 | 1,626 | N/A | N/A | N/A |
| TOTAL | $51,756 | $60,311 | $19,776 | $21,797 | $31,924 |
| Non-Current Assets | |||||
| PPE Net | 6,643 | 6,785 | 7,734 | 8,376 | 4,261 |
| Other Non-Current Assets | 6,868 | 6,617 | 8,665 | 8,167 | 7,965 |
| TOTAL | $13,511 | $13,402 | $16,399 | $16,543 | $12,226 |
| Total Assets | $65,267 | $73,713 | $36,175 | $38,340 | $44,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 393 | N/A | 393 | 396 | 563 |
| Accounts payable and accrued liabilities | 10,837 | 12,065 | 11,936 | 13,522 | 5,491 |
| Accrued Expenses | 9,934 | 10,209 | 9,067 | 9,108 | 8,928 |
| Other current liabilities | 541 | 393 | 5,445 | 10,355 | N/A |
| TOTAL | $21,705 | $22,667 | $26,841 | $33,381 | $14,982 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,066 | N/A | 5,768 | 6,449 | 3,520 |
| Other Non-Current Liabilities | 6,167 | 4,754 | 57 | 60 | 83 |
| TOTAL | $14,001 | $4,641 | $5,768 | $6,449 | $3,520 |
| Total Liabilities | $35,706 | $27,308 | $32,609 | $39,830 | $18,502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,263 | 10,981 | 9,699 | 5,668 | 4,554 |
| Common Shares | 1,875,284 | 1,872,885 | 1,810,035 | 1,784,646 | 1,753,473 |
| Retained earnings | -1,849,444 | -1,830,060 | -1,811,030 | -1,790,827 | -1,732,231 |
| Other shareholders' equity | 3,721 | 3,580 | 4,561 | 4,691 | 4,406 |
| TOTAL | $29,561 | $46,405 | $3,566 | $-1,490 | $25,648 |
| Total Liabilities And Equity | $65,267 | $73,713 | $36,175 | $38,340 | $44,150 |